Colin E Willoughby Selected Research

Colin E Willoughby Research Topics

Disease

12	Glaucoma 10/2023 - 06/2002
6	Keratoconus 01/2021 - 05/2013
4	Corneal Neovascularization 03/2018 - 06/2015
4	Retinitis Pigmentosa (Pigmentary Retinopathy) 08/2015 - 03/2011
3	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2022
3	Ocular Hypertension (Glaucoma, Suspect) 10/2023 - 01/2020
2	Neoplasms (Cancer) 01/2023 - 01/2022
2	Hereditary Corneal Dystrophies 11/2022 - 01/2016
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2020 - 04/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 03/2013
2	Ectrodactyly-cleft lip-palate syndrome 01/2016 - 01/2012
2	Thoracic Aortic Aneurysm 03/2015 - 12/2007
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2024
1	Diabetes Mellitus 05/2024
1	Eye Diseases (Eye Disease) 10/2023
1	Skin Diseases (Skin Disease) 09/2023
1	Keratitis-Ichthyosis-Deafness Syndrome 09/2023
1	Anhidrotic Ectodermal Dysplasia 1 01/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 09/2022
1	Disease Progression 01/2022
1	Corneal Endothelial Cell Loss 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Inflammation (Inflammations) 01/2021
1	Genetic Risk Score 01/2020
1	Epidermolysis Bullosa 04/2016
1	Blindness (Hysterical Blindness) 01/2016
1	Corneal Opacity 01/2016
1	Ciliopathies 08/2015
1	Retinal Diseases 02/2015
1	Brittle cornea syndrome 1 10/2014
1	Keratitis 11/2013
1	Corneal Edema 03/2013
1	Ectrodactyly 01/2012
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2011
1	Esotropia (Esophoria) 07/2009
1	Strabismus (Squint) 07/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2013
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
2	GlucocorticoidsIBA 10/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 11/2022 - 03/2018
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2018 - 11/2013
2	CollagenIBA 01/2018 - 05/2013
2	Retinaldehyde (Retinal)IBA 08/2015 - 02/2015
2	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 03/2015 - 12/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 03/2011
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 05/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2024
1	MicroRNAs (MicroRNA)IBA 10/2023
1	SteroidsIBA 10/2023
1	Ketoconazole (Nizoral)FDA LinkGeneric 09/2023
1	Lysine AcetyltransferasesIBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	LipidsIBA 09/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Biocompatible Materials (Biomaterials)IBA 03/2021
1	AcidsIBA 01/2021
1	AminesIBA 01/2021
1	ImidesIBA 01/2021
1	CytokinesIBA 01/2021
1	InflammasomesIBA 01/2021
1	GATIBA 01/2020
1	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2020
1	Riboflavin (Vitamin B2)FDA LinkGeneric 04/2018
1	Antisense OligonucleotidesIBA 03/2018
1	Oxygen (Dioxygen)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2015
1	RNA Precursors (Precursor, mRNA)IBA 08/2015
1	UbiquitinIBA 08/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2015
1	Mitochondrial DNA (mtDNA)IBA 04/2015
1	Rhodopsin (Visual Purple)IBA 01/2015
1	Coloring Agents (Dyes)IBA 11/2013
1	Membrane Transport Proteins (Biological Pump)IBA 03/2013
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	SolutionsIBA 03/2011
1	ElementsIBA 07/2009
1	Actins (F Actin)IBA 12/2007

Therapy/Procedure

9	Therapeutics 09/2023 - 06/2002
4	Corneal Transplantation (Keratoplasty) 01/2022 - 10/2014
2	Diathermy 07/2016 - 06/2015
1	Corneal Cross-Linking 12/2017
1	Keratectomy 01/2016
1	Lasers (Laser) 01/2016
1	Slit Lamp 01/2012
1	Contact Lenses 06/2002